Background/Objectives: Breast cancer (BC) represents a major public health problem that is influenced by social and systemic factors. This study evaluates disparities in the BC care continuum based on health insurance type and determines whether these patterns differ according to neighborhood-level deprivation. Methods: Using the Puerto Rico Central Cancer Registry-Health Insurance Linkage Database, we conducted a retrospective cohort study of women aged ≥18 years and diagnosed with BC in Puerto Rico between 2012 and 2016. The main outcomes were diagnostic delay (>60 days) and six-year mortality. Insurance type (private, Medicare, Medicaid, and dual enrollment in Medicare and Medicaid) was the main predictor, with neighborhood deprivation as a modifier. Logistic and Cox models assessed delay and survival, adjusting for key covariates. Results: Disparities in diagnostic delays and risk of death across insurance types were most evident in areas with low to average deprivation, whereas, in neighborhoods with above-average to highest deprivation, these differences diminished for diagnostic delay and disappeared for risk of death. Conclusions: These findings reveal that neighborhood environment, an intermediary social determinant of health, may affect the timeliness and quality of care provided to women diagnosed with BC.
Background: Breast cancer is the most common cancer among women globally. Early detection using mammography is crucial for improving outcomes and reducing aggressive treatment. Factors such as age, comorbidities, insurance coverage, and mental health conditions may influence screening behavior. Limited research exists on the relationship between mental health and breast cancer screening in Puerto Rico. This study examines factors associated with early detection among women aged 50 and older diagnosed with breast cancer and coexisting anxiety or affective disorder. Methods: We conducted a retrospective cohort study using data from the Puerto Rico Central Cancer Registry linked with the Health Insurance Linkage Database. Multivariable logistic regression was used to estimate adjusted odds ratios (AOR) to describe the relationship between having anxiety or affective disorder with the use of mammography and the stage at diagnosis. Cox proportional hazards model was used to assess the association between mental health diagnosis and risk of death, respectively. Results: Among 4,708 eligible women, 376 (8.0%) had an anxiety or affective disorder. Overall, 90.0% received a mammogram within 24 months prior to diagnosis, and 35.1% were diagnosed at a late stage. Women with anxiety or affective disorder were 57.0% more likely to have undergone screening (AOR 1.57, 95% confidence interval [CI]: 1.01–2.43; p = 0.046). These disorders were not significantly associated with cancer stage at diagnosis (AOR 0.86, 95% CI 0.68–1.09; p = 0.208) and did not increase the risk of death within 5 years (Adjusted Hazard Ratio [AHR] 1.01, 95% CI: 0.76–1.35; p = 0.094). Conclusion: In our study, anxiety or affective disorders were associated with increased mammography use but not with earlier cancer stages. Further research is needed on severe mental illness and the bidirectional relationship between cancer and mental health.
Background: Hospice services play an important role in end-of-life (EoL) care. In Puerto Rico, Medicaid had no provisions for hospice care until July 2024, representing a significant public health challenge. This study examined the association between hospice coverage policy and EoL outcomes among patients with cancer enrolled in Medicaid. Methods: This population-based retrospective cohort study analyzed data of cancer patients enrolled in Medicaid from the Puerto Rico Central Cancer Registry between 2011 and 2022 who died of cancer between 2016 and 2022. Hospice enrollment was categorized into timeframes before death: 1-7, 8-14, 15-30, 31-90, 91-120, and 121-180 days. We compared total costs, healthcare utilization, and death in acute settings by hospice enrollment status. Results: Of 4481 patients in the study, 21.7% were enrolled in hospice. Non-hospice-enrolled patients had higher healthcare expenditures for the last 7 ($548; 95% confidence interval [CI ]= $166 to $931), 14 ($1619; 95% CI = $894 to $2344), 30 ($3410; 95% CI = $2263 to $4557), 90 ($4896; 95% CI = $1987 to $7804), 120 ($6171; 95% CI = $61 to $12 281), and 180 ($19 291; 95% CI = $10 851 to $27 731) days than hospice-enrolled patients. Emergency department visit rates and hospitalization rates were higher for all periods (P < .05) for non-hospice-enrolled patients than for hospice-enrolled patients. Similarly, non-hospice-enrolled patients had a higher likelihood of dying in acute settings (P < .05). Conclusion: Hospice enrollment among Medicaid enrollees was associated with lower health expenditure, lower healthcare resource utilization, and a lower likelihood of mortality in an acute setting. The recent policy change to include hospice services coverage in Puerto Rico Medicaid is a positive step that must be sustained beyond 2027.
PURPOSE: Timely discussion of goals of care (GoC) between oncologists and patients with advanced cancer can improve end-of-life (EoL) decision making, ensuring that care aligns with individual preferences. However, barriers at multiple levels could limit timely EoL communication. This cross-sectional study examined oncologists' perceptions of barriers to GoC discussions regarding EoL processes among patients in Puerto Rico. METHODS: A 26-item questionnaire was distributed to oncologists in Puerto Rico, assessing three barrier domains (patient and family; physician; and systemic or external factors) and oncologists' willingness to engage in GoC discussions. Data were collected between April 2024 and January 2025. Descriptive statistics were used to summarize oncologists' characteristics. Differences in oncologists’ characteristics and willingness to engage in the decision-making process were assessed with the Mann-Whitney test (non-normally distributed data). Associations between barriers and oncologists' characteristics, such as age and training, were explored. RESULTS: A total of 60 oncologists across Puerto Rico (approximately 50% participation rate) completed the questionnaire. Over 65% identified patient- and family-related factors as the primary barriers to EoL discussions. Although 58.3% of oncologists had not received formal training in EoL, they did not perceive this as a significant barrier. Yet, those without formal training faced greater barriers. CONCLUSION: Family and patient factors emerged as the predominant barriers. Despite oncologists' willingness to engage in EoL discussions, the absence of formal training may hinder these conversations. Further research should focus on communication training and initiatives to provide oncologists, patients, and families with valuable resources for EoL decision making.